In the mifepristone case, the usually stalwart monitor of who can sue in federal court seemed awfully eager to relax the rules over “standing” on behalf of anti-abortion plaintiffs.
David Souter
Posted inPolitical Animal
In the mifepristone case, the usually stalwart monitor of who can sue in federal court seemed awfully eager to relax the rules over “standing” on behalf of anti-abortion plaintiffs.
As regulators tackle AI safety, they should also consider bias.
Keep readingSign up for the Washington Monthly newsletter to get our stories in your inbox. Opt out any time.